Two groups were different in cardiovascular risk study

doi:10.1136/bmj.327.7409.290-c

From trainee to consultant, BMJ Group offers doctors around the world tailored information, special events, learning resources and recruitment services at every step along their career path.

... by doctors, for doctors, for patients
We are open for entries!

Online learning

BMJ Learning

High-quality CME / CPD for doctors and other healthcare professionals. BMJ Learning features hundreds of accredited, peer-reviewed learning modules in text, video, and audio formats. Find out more

Courses and Qualifications

BMJ Masterclasses

BMJ Masterclasses, led by experts, help clinicians to use the latest evidence and recent guidelines in practice and meet their CPD/CME requirements. Find out more

Exam Preparation

The leading provider of online exam preparation, helping over 167,000 healthcare professionals to pass their exams. Find out more

onExamination

Search all BMJ comment articles:

From

Limit by

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Malvinder S Parmar, medical director (internal medicine) (atbeat@ntl.sympatico.ca)

Timmins and District Hospital, Timmins, ON, Canada P4N 8R1

EDITOR—Dunder et al compared two different groups and concluded that the incidence of myocardial infarction was significantly higher in the group receiving antihypertensive treatment.1

Table 1 shows two heterogeneous groups —the group with hypertension (having treatment) had higher blood glucose concentrations, body mass index, and proinsulin values (implying insulin resistance) than the other group, which had normal blood …